Publication:
The prevalence of Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) at testing centers in Belgium, Germany, Spain, and the UK using the cobas TV/MG molecular assay.

dc.contributor.authorPerry, Michael D
dc.contributor.authorJones, Sophie
dc.contributor.authorBertram, Alexander
dc.contributor.authorde Salazar, Adolfo
dc.contributor.authorBarrientos-Duran, Antonio
dc.contributor.authorSchiettekatte, Gilberte
dc.contributor.authorLewinski, Michael
dc.contributor.authorArcenas, Rodney
dc.contributor.authorHansra, Avneet
dc.contributor.authorNjoya, Merlin
dc.contributor.authorGarcia, Federico
dc.contributor.funderRoche Molecular Systems
dc.date.accessioned2023-05-03T13:35:51Z
dc.date.available2023-05-03T13:35:51Z
dc.date.issued2022-11-04
dc.description.abstractMycoplasma genitalium (MG) and Trichomonas vaginalis (TV) can lead to long-term sequelae in males and females; however, global prevalence data vary between geographical regions, as these sexually transmitted infections are not included in routine screening. The objective of this study was to use the cobas® TV/MG assay to assess the point prevalence of TV and MG in specimens from men and women over a broad European geographical area. Urine, vaginal, endocervical, and rectal samples were collected from patients aged ≥ 18 years receiving Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) screening as per local standard of care at sites in Belgium, Germany, Spain, and the UK (Wales). Remnant samples were assessed using the cobas TV/MG assay. Analysis of 2795 samples showed that MG prevalence varied slightly across female sample types (range: 1.7-5.8%; p = 0.0042). MG prevalence was higher in male rectal samples (12.5%) than in male urine samples (3.9%; p 
dc.description.versionSi
dc.identifier.citationPerry MD, Jones S, Bertram A, de Salazar A, Barrientos-Durán A, Schiettekatte G, et al. The prevalence of Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) at testing centers in Belgium, Germany, Spain, and the UK using the cobas TV/MG molecular assay. Eur J Clin Microbiol Infect Dis. 2023 Jan;42(1):43-52.
dc.identifier.doi10.1007/s10096-022-04521-5
dc.identifier.essn1435-4373
dc.identifier.pmcPMC9816248
dc.identifier.pmid36369413
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816248/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s10096-022-04521-5.pdf
dc.identifier.urihttp://hdl.handle.net/10668/20397
dc.issue.number1
dc.journal.titleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
dc.journal.titleabbreviationEur J Clin Microbiol Infect Dis
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.page.number43-52
dc.provenanceRealizada la curación de contenido 27/08/2024
dc.publisherSpringer
dc.pubmedtypeJournal Article
dc.relation.projectIDRD003557
dc.relation.publisherversionhttps://dx.doi.org/10.1007/s10096-022-04521-5
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectMolecular diagnostics
dc.subjectMycoplasma genitalium
dc.subjectPCR
dc.subjectPublic health
dc.subjectTrichomonas vaginalis
dc.subjectcobas TV/MG
dc.subject.decsAlemania
dc.subject.decsBélgica
dc.subject.decsChlamydia trachomatis
dc.subject.decsEnfermedades de transmisión sexual España
dc.subject.decsFemenino
dc.subject.decsGonorrea
dc.subject.decsHumanos
dc.subject.decsInfecciones por Chlamydia
dc.subject.decsInfecciones por Mycoplasma
dc.subject.decsMasculino
dc.subject.decsMycoplasma genitalium
dc.subject.decsNeisseria gonorrhoeae
dc.subject.decsPrevalencia
dc.subject.decsReino Unido
dc.subject.decsTrichomonas vaginalis
dc.subject.meshHumans
dc.subject.meshFemale
dc.subject.meshMale
dc.subject.meshTrichomonas vaginalis
dc.subject.meshMycoplasma genitalium
dc.subject.meshPrevalence
dc.subject.meshBelgium
dc.subject.meshSpain
dc.subject.meshSexually Transmitted Diseases
dc.subject.meshChlamydia trachomatis
dc.subject.meshNeisseria gonorrhoeae
dc.subject.meshGermany
dc.subject.meshUnited Kingdom
dc.subject.meshMycoplasma Infections
dc.subject.meshGonorrhea
dc.subject.meshChlamydia Infections
dc.titleThe prevalence of Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) at testing centers in Belgium, Germany, Spain, and the UK using the cobas TV/MG molecular assay.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number42
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PMC9816248.pdf
Size:
1.09 MB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Perry_ThePrevalence_MaterialSuplementario.docx
Size:
30.61 KB
Format:
Microsoft Word XML